Invitation: 14 May 2020 – The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies

On 14 May 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos will convene a briefing entitled: “The WHO Covid-19 Technology Pool: The solution to ensure global access to Covid-19 health technologies.” This side event in advance of the virtual 73rd session of the World Health Assembly will take place on 14 May 2020 from 15h00 CET to 16h30 CET.

Details on how to participate will be sent to registered attendees. Registration can be done by filling out this form.

Moderator: Ellen ‘t Hoen, LLM, PhD, Director, Medicines Law & Policy

Speakers:

  • Dr Mariângela Simão, Assistant Director-General Access to Medicines and Health Products, World Health Organization
  • Dr. Daniel Salas Peraza, Minister of Health, Costa Rica
  • Roman Macaya, MBA, PhD, Executive President of the Board of Directors of the Costa Rican Social Security Fund
  • Dr Philippe Duneton, Executive Director a.i., Unitaid
  • James Love, Director, Knowledge Ecology International (KEI)
  • Dr Marie-Paule Kieny, Director of research, Inserm, France; Chair of the Board, Drugs for Neglected Diseases Initiative (DNDi) and
    Medicines Patent Pool Foundation (MPPF), Geneva, Switzerland
  • Dr. Carlos María Correa, Executive Director, South Centre
  • Paul Fehlner, Paul Fehlner, PhD, President & CEO, reVision Therapeutics, Inc
  • Charles Gore, Executive Director, Medicines Patent Pool
  • Bernard Pecoul, Executive Director, Drugs for Neglected Diseases initiative (DNDi)

Look forward to seeing you there!

Avatar photo
+ posts

Kaitlin Mara, MSc, has been writing about international intellectual property and innovation policy for a over 15 years.

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

FDA approval of injectable lenacapavir for Pre-Exposure Prophylaxis (PrEP) opens the road to ending HIV

On 18th June 2025, the US Food and Drug Administration (FDA) approved the use of long-acting antiretroviral medicine lenacapavir (LEN-LA), for the prevention of...

Transfer of technology and know-how for the production of pandemic-related health products in the WHO Pandemic Agreement: The proverbial half glass 

A version of this brief was published on 13 June '25 by the Graduate Institute as part of their 'Governing Pandemic Snapshot' series: https://www.governingpandemics.org/gp-snapshot During...

The People vs. AbbVie

Today, 9 May 2025, is an important day in court for the Dutch Pharmaceutical Accountability Foundation (PAF). In February 2023, PAF started a court...

The Pandemic Agreement is here

In December 2021, the member states of the World Health Organization decided “to draft and negotiate a WHO convention, agreement or other international instrument...

Expanding local production is essential for pandemic preparedness. It requires, however, transfer of technology.

Madam co-chairs, delegates,  This very week, from 7 to 9 April the 3rd World Local Production Forum is taking place in Abu Dhabi. Actions towards...

Related Articles